A Phase 3 Randomized Double-Blind Multicenter Study of Sonrotoclax Plus Zanubrutinib Versus Placebo Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma
Clinical Trial Grant
Awarded By
BeOne Medicines USA, Inc.
Start Date
September 4, 2025
End Date
August 31, 2030
Awarded By
BeOne Medicines USA, Inc.
Start Date
September 4, 2025
End Date
August 31, 2030